PMC:7696151 / 11017-11302
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 303 | 15-23 | Species | denotes | patients | Tax:9606 |
| 304 | 147-155 | Species | denotes | patients | Tax:9606 |
| 305 | 273-278 | Species | denotes | HIV-1 | Tax:11676 |
| 324 | 80-83 | Chemical | denotes | HCQ | MESH:D006886 |
| 325 | 107-110 | Chemical | denotes | ZDV | MESH:D015215 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T91 | 25-120 | Sentence | denotes | All subjects were treated for 16 weeks with 800 mg/day HCQ (n = 35) or 500 mg/day ZDV (n = 37). |
| T92 | 121-243 | Sentence | denotes | As in the previous study, patients who had received HAART stopped taking it four weeks before the clinical trial’s outset. |